Mechanisms that regulate the anticoagulant function of coagulation factor V

REFERENCES

• Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363–70.
   Google Scholar
• Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1988; 53: 505 — 18.
   Google Scholar
• Jenny RJ, Tracy PB, Mann KG. The physiology and biochemistry of factor V. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, editors. Haemostasis and Thrombosis, 3rd ed. Edinburgh: Churchill Livingstone, 1994: 465 — 76.
   Google Scholar
• Kane WH, Davie EW. Blood coagulation factors V and VIII: Structural and functional similarities and their relationship to hemorrhagic and trombotic disorders. Blood 1988; 71: 539 — 55.
   Google Scholar
• Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348 — 52.
   Google Scholar
• Esmon CT. The protein C anticoagulant pathway. Arterioscler Thromb 1992; 12: 135 — 45.
   Google Scholar
• Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res 1995; 77: 1 — 43.
   Google Scholar
• Walker FJ. Regulation of activated protein C by a new protein. J Biol Chem 1980; 255: 5521–4.
   Google Scholar
• Bakker H, Tans G, Janssen-Claessen T, Thomassen MCLGD, Hemker HC, Griffin JH, etal. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C. Eur J Biochem 1992; 208: 171–8.
   Google Scholar
• Walker FJ. Regulation of activated protein C by protein S, the role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256: 11128 — 31.
   Google Scholar
• Yegneswaran D, Wood GM, Esmon CT, Johnson AE. Protein S alters the active site of activated pro-tein C above the membrane surface. J Biol Chem 1997; 272: 25013 — 21.
   Google Scholar
• Griffin JH, Evatt BL, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370 — 3.
   Google Scholar
• Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297 — 300.
   Google Scholar
• Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082 — 8.
   Google Scholar
• Koster T, Rosendaal FR, de Ronde F, Briet E, Vandenbroucke JP, Bertina RM. Venous throm-bosis due to poor response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342: 1503 — 6.
   Google Scholar
• Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517 — 21.
   Google Scholar
• Griffin JH, Evatt BL, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in a majority of thrombophilic patients. Blood 1993; 82: 1989 — 93.
   Google Scholar
• Dahlbäck B. Physiological anticoagulation. Inher-ited resistance to activated protein C and venous thromboembolism. J Clin Invest 1994; 94: 923–7.
   Google Scholar
• Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant responce to activated protein C. Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004 — 8.
   Google Scholar
• Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994; 91: 1396— 400.
   Google Scholar
• Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor Villa. J Biol Chem 1994; 269: 18735 — 8.
   Google Scholar
• Thorelli E, Kaufman RJ, Dahlbäck B. Cleavage requirements for activation of factor V by factor Xa. Eur J Biochem 1997; 247: 12 — 20.
   Google Scholar
• Thorelli E, Kaufman RJ, Dahlbäck B. Cleavage requirements of factor V in tissue-factor induced thrombin generation. Thromb Haemost 1998; 80: 92 — 8.
   Google Scholar
• Suzuki K, Dahlbäck B, Stenflo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257: 6556 — 64.
   Google Scholar
• Thorelli E, Kaufman RJ, Dahlbäck B. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V. J Biol Chem 1998; 273: 16140 — 5.
   Google Scholar
• Varadi K, Rosing J, Tans G, Pabinger I, Keil B, Schwarz HP. Factor V enhances the cofactor func-tion of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR5°6Q muta-tion. Thromb Haemost 1996; 76: 208 — 14.
   Google Scholar
• Varadi K, Rosing J, Tans G, Schwarz HP. Influence of factor V and factor Va on APC-induced cleavage of human factor VIII (letter). Thromb Haemost 1995; 73 (4): 730 — 1.
   Google Scholar
• Lu D, Kalafatis M, Mann KG, Long GL. Compar-ison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V. Blood 1996; 87: 4708— 17.
   Google Scholar
• Villoutreix BO, Dahlbäck B. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling. Protein Sci 1998; 7: 1317–25.
   PubMedGoogle Scholar
• Hortin GL. Sulfation of tyrosine residues in coagu-lation factor V. Blood 1990; 76: 946 — 52.
   Google Scholar
• Pittman DD, Tomkinson KN, Michnick D, Selighson U, Kaufman RJ. Posttranslational sulfa-tion of factor V is required for efficient thrombin cleavage and activiation and for full procoagulant activity. Biochemistry 1994; 33: 6952— 59.
   Google Scholar
• Zaitseva I, Zaitsev V, Card G, Moshkov K, Box B, Ralph A, Lindley P. The x-ray structure of human serum ceruloplasmin at 3.1 A: nature of the copper centres. J Biol Inorg Chem 1996; 1: 15 — 23.
   Google Scholar
• Stoylova S, Mann KG, Brisson A. Structure of membrane-bound human factor Va. FEBS Letter 1994; 351: 330–4.
   Google Scholar
• Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resis-tance to activated protein C. Nature 1994; 369: 64–7.
   Google Scholar
• Zöller B, Svensson PJ, He X, Dahlbäck B. Identifi-cation of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521–4.
   Google Scholar